Amedeo Smart

Free Medical Literature Service


 

Amedeo

Bladder Cancer

  Free Subscription

Articles published in
Urol Int
    June 2021
  1. GAO T, Ji Y
    Long Noncoding RNA LINC00707 Accelerates Tumorigenesis and Progression of Bladder Cancer via Targeting miR-145/CDCA3 Regulatory Loop.
    Urol Int. 2021 Jun 30:1-15. doi: 10.1159/000514388.
    >> Share

    March 2021
  2. CHEN P, Chen J, He L, Du C, et al
    Identification of circRNA-miRNA-mRNA Regulatory Network in Bladder Cancer by Integrated Analysis.
    Urol Int. 2021 Mar 31:1-11. doi: 10.1159/000512066.
    >> Share

  3. LIU Y, Huang X, Guo L, Luo N, et al
    LINC00649 Facilitates the Cellular Process of Bladder Cancer Cells via Signaling Axis miR-16-5p/JARID2.
    Urol Int. 2021 Mar 31:1-9. doi: 10.1159/000506239.
    >> Share

  4. LIU Z, Zhang Y, Sun G, Ouyang W, et al
    Comparison of Thulium Laser Resection of Bladder Tumors and Conventional Transurethral Resection of Bladder Tumors for Non-Muscle-Invasive Bladder Cancer.
    Urol Int. 2021 Mar 30:1-6. doi: 10.1159/000514042.
    >> Share

    February 2021
  5. YANG X, Zhuang J, Yu H, Cao Q, et al
    Effect of Coronavirus Disease 2019 on Patients with Bladder Cancer in China.
    Urol Int. 2021 Feb 24:1-3. doi: 10.1159/000512895.
    >> Share

    January 2021
  6. KAYNAR M, Celik ZE, Altintas E, Batur AF, et al
    Comparison of Two Different Bipolar Energy Resources in Transurethral Resection of Bladder Tumors.
    Urol Int. 2021;105.
    >> Share

  7. IZOL V, Deger M, Ozden E, Bolat D, et al
    The Effect of Diagnostic Ureterorenoscopy on Intravesical Recurrence in Patients Undergoing Nephroureterectomy for Primary Upper Tract Urinary Carcinoma.
    Urol Int. 2021;105.
    >> Share

  8. YANG C, Lv Z, Li Y
    Reduction of Bladder Volume after BCG Immunotherapy.
    Urol Int. 2021;105.
    >> Share

    December 2020
  9. RABER M, Buchholz N, Vercesi A, Hendawi NA, et al
    Treatment of Large Non-Muscle-Invasive Bladder Cancer: The Potential Role of Neoadjuvant Intravesical Chemotherapy.
    Urol Int. 2020 Dec 17:1-6. doi: 10.1159/000512052.
    >> Share

    August 2020
  10. MAISCH P, Retz M, Gschwend JE, Koll F, et al
    Clinical Practice Guidelines for Bladder Cancer: A Systematic Review and Meta-Analysis Using the AGREE II Instrument.
    Urol Int. 2020 Aug 21:1-10. doi: 10.1159/000509431.
    >> Share

    July 2020
  11. CHEN G, Yang T, Shao Q, Zhang M, et al
    Sub-Staging-Specific Differences in Recurrence-Free, Progression-Free, and Cancer-Specific Survival for Patients with T1 Bladder Cancer: A Systematic Review and Meta-Analysis.
    Urol Int. 2020 Jul 1:1-7. doi: 10.1159/000506238.
    >> Share

    June 2020
  12. WU J, Wang YC, Luo WJ, Dai B, et al
    Diagnostic Performance of Confocal Laser Endomicroscopy for the Detection of Bladder Cancer: Systematic Review and Meta-Analysis.
    Urol Int. 2020 Jun 18:1-10. doi: 10.1159/000508417.
    >> Share

  13. NAKANE K, Enomoto T, Hishida S, Tomioka M, et al
    The Utility and Efficacy of Laparoscopic Radical Cystectomy in Patients with Muscle-Invasive Bladder Cancer at a Single Institution.
    Urol Int. 2020 Jun 17:1-7. doi: 10.1159/000508192.
    >> Share

  14. BUSETTO GM, Porreca A, Del Giudice F, Maggi M, et al
    SARS-CoV-2 Infection and High-Risk Non-Muscle-Invasive Bladder Cancer: Are There Any Common Features?
    Urol Int. 2020 Jun 9:1-13. doi: 10.1159/000509065.
    >> Share

    May 2020
  15. XU J, Wang C, Ouyang J, Sun J, et al
    Efficacy and Safety of Transurethral Laser Surgery Versus Transurethral Resection for Non-Muscle-Invasive Bladder Cancer: A Meta-Analysis and Systematic Review.
    Urol Int. 2020 May 27:1-14. doi: 10.1159/000506655.
    >> Share

  16. SERRETTA V, Di Maida F, Baiamonte D, Vella M, et al
    Does Smoking Cessation at Primary Diagnosis Reduce the Recurrence Risk of Nonmuscle-Invasive Bladder Cancer? Results of a Prospective Study.
    Urol Int. 2020 May 5:1-6. doi: 10.1159/000507122.
    >> Share

    March 2020
  17. SUAREZ-IBARROLA R, Hein S, Farin E, Waldbillig F, et al
    Current Standards in the Endoscopic Management of Bladder Cancer: A Survey Evaluation among Urologists in German-Speaking Countries.
    Urol Int. 2020 Mar 25:1-7. doi: 10.1159/000506653.
    >> Share

    January 2020
  18. YANG H, Lin J, Gao P, He Z, et al
    Is the En Bloc Transurethral Resection More Effective than Conventional Transurethral Resection for Non-Muscle-Invasive Bladder Cancer? A Systematic Review and Meta-Analysis.
    Urol Int. 2020 Jan 7:1-8. doi: 10.1159/000503734.
    >> Share

  19. SUZUKI K, Hinata N, Inoue TA, Nakamura I, et al
    Comparison of the Perioperative and Postoperative Outcomes of Ileal Conduit and Cutaneous Ureterostomy: A Propensity Score-Matched Analysis.
    Urol Int. 2020;104.
    >> Share

  20. POLETAJEW S, Krajewski W, Adamowicz J, Kolodziej A, et al
    Management of Intradiverticular Bladder Tumours: A Systematic Review.
    Urol Int. 2020;104.
    >> Share

  21. JOKISCH JF, Grimm T, Buchner A, Kretschmer A, et al
    Preoperative Thrombocytosis in Patients Undergoing Radical Cystectomy for Urothelial Cancer of the Bladder: An Independent Prognostic Parameter for an Impaired Oncological Outcome.
    Urol Int. 2020;104.
    >> Share

  22. ZHU C, Deng Z, Yuan L, Su J, et al
    Transurethral-Assisted Transumbilical Laparoendoscopic Single-Site Radical Cystectomy: Initial Short-Term Experience.
    Urol Int. 2020;104.
    >> Share

  23. SARIER M, Sepin N, Keles Y, Imir L, et al
    Is There any Association between Urothelial Carcinoma of the Bladder and Human Papillomavirus? A Case-Control Study.
    Urol Int. 2020;104.
    >> Share

  24. FROEHNER M, Koch R, Heberling U, Borkowetz A, et al
    Validation of a Questionnaire-Suitable Comorbidity Index in Patients Undergoing Radical Cystectomy.
    Urol Int. 2020;104.
    >> Share

  25. FEDELI U, De Paoli A, Corti MC, Cacciamani GE, et al
    Perioperative Mortality and Long-Term Survival after Radical Cystectomy: A Population-Based Study in a Southern European Country on 4,389 Patients.
    Urol Int. 2020;104.
    >> Share

  26. TAMALUNAS A, Buchner A, Kretschmer A, Jokisch F, et al
    Impact of Routine Laboratory Parameters in Patients Undergoing Radical Cystectomy for Urothelial Carcinoma of the Bladder: A Long-Term Follow-Up.
    Urol Int. 2020;104.
    >> Share

    December 2019
  27. ZIEGELMUELLER BK, Jokisch JF, Buchner A, Grimm T, et al
    Long-Term Follow-Up and Oncological Outcome of Patients Undergoing Radical Cystectomy for Bladder Cancer following an Enhanced Recovery after Surgery (ERAS) Protocol: Results of a Large Randomized, Prospective, Single-Center Study.
    Urol Int. 2019 Dec 4:1-7. doi: 10.1159/000504236.
    >> Share

    October 2019
  28. FROEHNER M, Muallah D, Koch R, Hubler M, et al
    Socioeconomic Status-Related Parameters as Predictors of Competing (Non-Bladder Cancer) Mortality after Radical Cystectomy.
    Urol Int. 2019 Oct 22:1-8. doi: 10.1159/000502781.
    >> Share

    September 2019
  29. HAUTMANN RE, Bolenz C, Volkmer B
    Unexpected Early Oncologic Mortality after Open Radical Cystectomy for Bladder Cancer: Who Is to Be Blamed?
    Urol Int. 2019 Sep 27:1-6. doi: 10.1159/000503398.
    >> Share

    August 2019
  30. YOO SH, Kim H, Kwak C, Kim HH, et al
    Late Recurrence of Bladder Cancer following Radical Cystectomy: Characteristics and Outcomes.
    Urol Int. 2019 Aug 28:1-6. doi: 10.1159/000502656.
    >> Share

  31. CARANDO R, Zazzara M, Cotrufo S, Ludovico GM, et al
    Intravesical Treatment with Electro-Mediated Administration of Mytomicin C as Prophylaxis for Intermediate and High-Risk Nonmuscle-Invasive Bladder Cancer: A Retrospective Multicenter Study.
    Urol Int. 2019 Aug 28:1-6. doi: 10.1159/000502663.
    >> Share

    June 2019
  32. BI H, Huang Y, Wang G, Ma L, et al
    Impact of Body Mass Index and Pretreatment Hemoglobin Level on Prognosis Following Radical Cystectomy for Bladder Cancer in Males and Females.
    Urol Int. 2019 Jun 18:1-8. doi: 10.1159/000500561.
    >> Share

    March 2019
  33. CARRION A, Diaz F, Raventos C, Lozano F, et al
    Comparison of Outcomes between Standard and Palliative Management for High Grade Non-Muscle Invasive Bladder Cancer in Patients Older than 85 Years.
    Urol Int. 2019 Mar 7:1-7. doi: 10.1159/000496802.
    >> Share

    January 2019
  34. GROEBEN C, Koch R, Baunacke M, Borkowetz A, et al
    In-Hospital Outcomes after Radical Cystectomy for Bladder Cancer: Comparing National Trends in the United States and Germany from 2006 to 2014.
    Urol Int. 2019 Jan 30:1-9. doi: 10.1159/000496347.
    >> Share

  35. MOSCHINI M, Zamboni S, Mattei A, Baumeister P, et al
    Radical Cystectomy in Pathological T4a and T4b Bladder Cancer Patients: Is There Any Space for Sub Stratification?
    Urol Int. 2019 Jan 29:1-8. doi: 10.1159/000493899.
    >> Share

  36. ZIESCHANG H, Koch R, Wirth MP, Froehner M, et al
    Leiomyosarcoma of the Urinary Bladder in Adult Patients: A Systematic Review of the Literature and Meta-Analysis.
    Urol Int. 2019;102:96-101.
    >> Share

  37. LI A, Zhang P, Zhang M, Yang T, et al
    Transurethral Enucleation of Bladder Leiomyoma: A Series of Six Cases and Review of the Literature.
    Urol Int. 2019;102:102-108.
    >> Share

  38. SHIGEMURA K, Tanaka K, Hamasuna R, Ishikawa K, et al
    Efficacy of Prophylactic Antimicrobial Administration of Tazobactam/Piperacillin for Radical Cystectomy with Urinary Diversion: A Multicenter Study.
    Urol Int. 2019;102:293-298.
    >> Share

  39. URBINA-LIMA AD, Roman-Martin AA, Crespo-Santos A, Martinez-Rodriguez A, et al
    Solitary Fibrous Tumor of the Urinary Bladder Associated with Hypoglycemia: An Unusual Case of Doege-Potter Syndrome.
    Urol Int. 2019;103:120-124.
    >> Share

  40. SCHULZ GB, Grimm T, Buchner A, Kretschmer A, et al
    Benefits and Complications during the Stay at an Early Rehabilitation Facility after Radical Cystectomy and Orthotopic Ileum Neobladder Reconstruction.
    Urol Int. 2019;103:350-356.
    >> Share

  41. AZNAR MARTINEZ L, Lopez Cubillana P, Lopez Abad A, Vidal Crespo N, et al
    Bacillus Calmette-Guerin in Immunosuppressed Patient with High-Grade Nonmuscle Invasive Bladder Carcinoma.
    Urol Int. 2019;103:242-244.
    >> Share

    November 2018
  42. SANGUEDOLCE F, Russo D, Mancini V, Selvaggio O, et al
    Human Epidermal Growth Factor Receptor 2 in Non-Muscle Invasive Bladder Cancer: Issues in Assessment Methods and Its Role as Prognostic/Predictive Marker and Putative Therapeutic Target: A Comprehensive Review.
    Urol Int. 2018 Nov 21:1-13. doi: 10.1159/000494359.
    >> Share

  43. LAUSENMEYER EM, Braun K, Breyer J, Gierth M, et al
    Strong Expression of Cancertestis Antigens CTAG1B and MAGEA3 Is Correlated with Unfavourable Histopathological Features and MAGEA3 Is Associated with Worse Progression-Free Survival in Urothelial Bladder Cancer.
    Urol Int. 2018 Nov 1:1-6. doi: 10.1159/000493577.
    >> Share

    September 2018
  44. BOSSCHIETER J, Nieuwenhuijzen JA, Hentschel A, Vis AN, et al
    Value of a Marker Lesion in Non-Muscle-Invasive Bladder Cancer Patients Treated with Interleukin-2 Instillations: A Randomized Controlled Multicentre Trial.
    Urol Int. 2018 Sep 28:1-8. doi: 10.1159/000493159.
    >> Share

  45. KRAJEWSKI W, Zdrojowy R, Dembowski J, Poletajew S, et al
    The Optimal Timing of Restaging Resection before Introduction of Bacillus Calmette-Guerin Immunotherapy in Patients with High-Risk Non-Muscle-Invasive Bladder Cancer.
    Urol Int. 2018 Sep 28:1-9. doi: 10.1159/000491642.
    >> Share

  46. VETTERLEIN MW, Gild P, Marks P, Roschinski J, et al
    Evaluating Guideline Adherence for T1 Bladder Cancer Treatment and Surveillance: A Retrospective German Multicenter Observation.
    Urol Int. 2018 Sep 20:1-8. doi: 10.1159/000493369.
    >> Share

  47. KRAJEWSKI W, Matuszewski M, Poletajew S, Grzegrzolka J, et al
    Are There Differences in Toxicity and Efficacy between Various Bacillus Calmette-Guerin Strains in Bladder Cancer Patients? Analysis of 844 Patients.
    Urol Int. 2018 Sep 18:1-8. doi: 10.1159/000492722.
    >> Share

    August 2018
  48. MARI A, D'Andrea D, Kimura S, Resch I, et al
    Sarcopenia as a Predictive Factor for Response to Upfront Cisplatin-Based Chemotherapy in Patients with Muscle-Invasive Urothelial Bladder Cancer.
    Urol Int. 2018;101:1-4.
    >> Share

    May 2018
  49. DRAEGER DL, Sievert KD, Hakenberg OW
    Psychosocial Distress in Bladder Cancer Stratified by Gender, Age, Treatment, and Tumour Stage.
    Urol Int. 2018 May 14:1-7. doi: 10.1159/000489502.
    >> Share

    March 2018
  50. CERRUTO MA, D'Elia C, Siracusano S, Saleh O, et al
    Health-Related Quality of Life after Radical Cystectomy for Bladder Cancer in Elderly Patients with Ileal Orthotopic Neobladder or Ileal Conduit: Results from a Multicentre Cross-Sectional Study Using Validated Questionnaires.
    Urol Int. 2018 Mar 7. pii: 000487644. doi: 10.1159/000487644.
    >> Share

  51. DOGAN S, Hennig M, Frank T, Struck JP, et al
    Acceptance of Adjuvant and Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer in Germany: A Survey of Current Practice.
    Urol Int. 2018 Mar 6. pii: 000487405. doi: 10.1159/000487405.
    >> Share

    January 2018
  52. ZUCCHI A, Costantini E
    "Nested Type" Bladder Cancer: Myth or Reality?
    Urol Int. 2018 Jan 17. pii: 000486533. doi: 10.1159/000486533.
    >> Share

  53. TAN P, Xie N, Yang L, Liu L, et al
    Diagnostic Ureteroscopy Prior to Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma Increased the Risk of Intravesical Recurrence.
    Urol Int. 2018;100:92-99.
    >> Share

  54. PALAZZETTI A, Bosio A, Dalmasso E, Destefanis P, et al
    De Novo Bladder Urothelial Neoplasm in Renal Transplant Recipients: A Retrospective, Multicentered Study.
    Urol Int. 2018;100:185-192.
    >> Share

  55. NIEGISCH G, Nini A, Michalski R, Henn A, et al
    Comparison of 2-Year Oncological Outcome and Early Recurrence Patterns in Patients with Urothelial Bladder Carcinoma Treated with Open or Robot-Assisted Radical Cystectomy with an Extracorporeal Urinary Diversion.
    Urol Int. 2018;101:224-231.
    >> Share

  56. GONZALEZ-PEREZ L, Alvarez-Arguelles H, Ramos Gutierrez VJ, Hernandez SG, et al
    Bladder Fetal Rhabdomyoma Intermediate Type.
    Urol Int. 2018;101:240-244.
    >> Share

  57. SANGUEDOLCE F, Landriscina M, Ambrosi A, Tartaglia N, et al
    Bladder Metastases from Breast Cancer: Managing the Unexpected. A Systematic Review.
    Urol Int. 2018;101:125-131.
    >> Share

  58. FERRO M, Vartolomei MD, Cantiello F, Lucarelli G, et al
    High-Grade T1 on Re-Transurethral Resection after Initial High-Grade T1 Confers Worse Oncological Outcomes: Results of a Multi-Institutional Study.
    Urol Int. 2018;101:7-15.
    >> Share

  59. BEN BAHRIA-SEDIKI I, Chebil M, Sampaio C, Martel-Frachet V, et al
    Prognostic Value of Soluble Death Receptor Ligands in Patients with Transitional Cell Carcinoma of Bladder.
    Urol Int. 2018;100:476-484.
    >> Share

  60. GIERTH M, Zeman F, Denzinger S, Vetterlein MW, et al
    Influence of Body Mass Index on Clinical Outcome Parameters, Complication Rate and Survival after Radical Cystectomy: Evidence from a Prospective European Multicentre Study.
    Urol Int. 2018;101:16-24.
    >> Share

  61. TAE BS, Ku JH, Kwak C, Kim HH, et al
    Comparison of Renal Function after Radical Surgery for Upper Tract Urothelial Carcinoma versus Renal Cell Carcinoma: Propensity Score Matching.
    Urol Int. 2018;101:400-408.
    >> Share

  62. BO S, Donghao S, Guangqi K, Ye T, et al
    CC Chemokine Ligand 18 Promotes Cell Proliferation and Metastasis of Urothelial Carcinoma via Activating PI3K/mTOR Signaling in Patient with Renal Transplantation.
    Urol Int. 2018;101:450-458.
    >> Share

    December 2017
  63. ZATTONI F, Palumbo V, Giannarini G, Crestani A, et al
    Perioperative Outcomes and Early Survival in Octogenarians Who Underwent Radical Cystectomy for Bladder Cancer.
    Urol Int. 2017 Dec 7. pii: 000478990. doi: 10.1159/000478990.
    >> Share

    June 2017
  64. NAGAO K, Hara T, Nishijima J, Shimizu K, et al
    The Efficacy of Trimodal Chemoradiotherapy with Cisplatin as a Bladder-Preserving Strategy for the Treatment of Muscle-Invasive Bladder Cancer.
    Urol Int. 2017 Jun 21. doi: 10.1159/000477912.
    >> Share

  65. POLETAJEW S, Zapala P, Radziszewski P
    Safety and Efficacy of Intravesical Bacillus Calmette-Guerin Immunotherapy in Patients with Non-Muscle-Invasive Bladder Cancer Presenting with Asymptomatic Bacteriuria: A Systematic Review.
    Urol Int. 2017 Jun 10. doi: 10.1159/000477673.
    >> Share

    April 2017
  66. BALCI M, Tuncel A, Keten T, Guzel O, et al
    Comparison of Monopolar and Bipolar Transurethral Resection of Non-Muscle Invasive Bladder Cancer.
    Urol Int. 2017 Apr 6. doi: 10.1159/000467397.
    >> Share

    March 2017
  67. NAKAMURA Y, Yoshida S, Tanaka H, Inoue M, et al
    Potential Utility of Diffusion-Weighted Magnetic Resonance Imaging in Diagnosis of Residual Bladder Cancer before Second Transurethral Resection.
    Urol Int. 2017 Mar 1. doi: 10.1159/000456722.
    >> Share

    February 2017
  68. MOSCHINI M, Shariat SF, Freschi M, Soria F, et al
    Impact of Prostate Involvement on Outcomes in Patients Treated with Radical Cystoprostatectomy for Bladder Cancer.
    Urol Int. 2017 Feb 1. doi: 10.1159/000454736.
    >> Share

    January 2017
  69. LONG X, Qi L, Zu X, Li Y, et al
    Prevention of Recurrent Bladder Tumors after Nephroureterectomy for Primary Upper Urinary Tract Urothelial Carcinoma: An Individualized Selection Strategy Based on Patient Risk Stratification Is Needed.
    Urol Int. 2017;98:312-319.
    >> Share

  70. WOLTERS M, Oelke M, Lutze B, Weingart M, et al
    Deep Surgical Site Infections after Open Radical Cystectomy and Urinary Diversion Significantly Increase Hospitalisation Time and Total Treatment Costs.
    Urol Int. 2017;98:268-273.
    >> Share

    December 2016
  71. BREYER J, Otto W, Wirtz RM, Wullich B, et al
    ERBB2 Expression as Potential Risk-Stratification for Early Cystectomy in Patients with pT1 Bladder Cancer and Concomitant Carcinoma in situ.
    Urol Int. 2016.
    >> Share

  72. D'ELIA C, Comploj E, Cerruto MA, Trenti E, et al
    90-Day Mortality after Radical Cystectomy for Bladder Cancer: Prognostic Factors in a Multicenter Case Series.
    Urol Int. 2016.
    >> Share

    January 2016
  73. SOORIAKUMARAN P, Chiocchia V, Dutton S, Pai A, et al
    Predictive Factors for Time to Progression after Hyperthermic Mitomycin C Treatment for High-Risk Non-Muscle Invasive Urothelial Carcinoma of the Bladder: An Observational Cohort Study of 97 Patients.
    Urol Int. 2016;96:83-90.
    >> Share

  74. SERRETTA V, Scalici Gesolfo C, Alonge V, Cicero G, et al
    Does the Compliance to Intravesical BCG Differ between Common Clinical Practice and International Multicentric Trials?
    Urol Int. 2016;96:20-4.
    >> Share

  75. MARTINI T, Aziz A, Roghmann F, Rink M, et al
    Prediction of Locally Advanced Urothelial Carcinoma of the Bladder Using Clinical Parameters before Radical Cystectomy--A Prospective Multicenter Study.
    Urol Int. 2016;96:57-64.
    >> Share

  76. MILLER K, Morant R, Stenzl A, Zuna I, et al
    A Phase II Study of the Central European Society of Anticancer-Drug Research (CESAR) Group: Results of an Open-Label Study of Gemcitabine plus Cisplatin with or without Concomitant or Sequential Gefitinib in Patients with Advanced or Metastatic Transi
    Urol Int. 2016;96:5-13.
    >> Share

  77. TANAKA H, Yoshida S, Komai Y, Sakai Y, et al
    Clinical Value of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Upper Tract Urothelial Carcinoma: Impact on Detection of Metastases and Patient Management.
    Urol Int. 2016;96:65-72.
    >> Share

  78. GAKIS G, Efstathiou JA, Daneshmand S, Keegan KA, et al
    Oncological Outcomes of Patients with Concomitant Bladder and Urethral Carcinoma.
    Urol Int. 2016;97:134-41.
    >> Share

  79. D''AGOSTINO D, Racioppi M, Pugliese D, Ragonese M, et al
    Postoperative Quality of Life in Patients with Ileal Neobladder at Short-, Intermediate- and Long-Term Follow-Up.
    Urol Int. 2016;97:54-60.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016